Project Number 5R01AG071522-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (Rest) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) o. Circadian Rhythm Researcher and Organization Principal Investigator GREENBERG, BARRY DAVID Principal Investigator First Name BARRY DAVID Principal Investigator Last Name GREENBERG Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $748,283 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
